Sarepta Therapeutics, Inc. (SRPT) Trading Down 0% on Insider Selling

The stock declined 0.63% or $0.89 reaching $140.43 per share. Mutual of America Capital Management LLC now owns 60,108 shares of the company's stock valued at $2,319,000 after buying an additional 358 shares in the last quarter. Johnson & Johnson now has $377.27B valuation. Investors saw a positive move of 6.18% in last five trading days. Sarepta Therapeutics Inc (NASDAQ:SRPT) has risen 96.82% since November 9, 2016 and is uptrending. It has outperformed by 80.12% the S&P500. Eagle Asset Management Inc. boosted its position in shares of Sarepta Therapeutics by 33.4% during the second quarter.

SRPT is now undervalued by -24.26% relative to the average 1-year price target of $69.24 taken from a group of Wall Street Analysts. BlackRock Inc. now owns 5,292,729 shares of the biotechnology company's stock valued at $156,664,000 after purchasing an additional 5,175,193 shares in the last quarter. Sarepta Therapeutics has a one year low of $8.00 and a one year high of $63.73. Oppenheimer Holdings now has a "Buy" rating and a $76.00 price target on the stock.

About 3.10M shares traded or 40.27% up from the average. Columbus Circle Investors now owns 121,758 shares of the biotechnology company's stock worth $5,457,000 after acquiring an additional 73,395 shares during the period. Array Biopharma Inc (NASDAQ:ARRY) was raised too.

Investors sentiment increased to 1.52 in 2017 Q2. Its up 0.09, from 1.43 in 2017Q1. Hedge funds and other institutional investors own 65.58% of the company's stock. 30 funds opened positions while 61 raised stakes. The Ontario - Canada-based Canada Pension Plan Investment Board has invested 0% in Sarepta Therapeutics Inc (NASDAQ:SRPT). Ameritas Investment Partners Inc holds 4,561 shares. Camber Cap Mngmt Limited Liability Corp has 1.30M shares. Geode Capital Management Ltd Llc has 0.01% invested in Sarepta Therapeutics Inc (NASDAQ:SRPT) for 446,269 shares.

Traders have different rules for what constitutes liquidity and a good guide is the volume of trades and volume of shares that are traded each day. Active Investors often continue a close observation on any stock volume. During the same period in the prior year, the company earned ($0.95) EPS. equities research analysts expect that Sarepta Therapeutics will post -3.11 EPS for the current fiscal year. Shares of ICON Public Limited Company (ICLR) weakened with poorly motion. Tiaa Cref Lc reported 166,089 shares. This presents short term, intermediate and long term technical levels of Sarepta Therapeutics, Inc. Virginia-based Thompson Davis has invested 0.01% in Vanda Pharmaceuticals Inc. Parametric Portfolio Assocs Limited Liability Com holds 0% or 36,919 shares. Architects Inc holds 0.01% or 5,000 shares in its portfolio. The average investment recommendation on a scale of 1 to 5 (1 being a strong buy, 3 a hold, and 5 a sell) is 1.80, which implies that analysts are generally bullish in their outlook for SRPT over the next year. Therefore 100% are positive. Cowen & Co maintained Sarepta Therapeutics Inc (NASDAQ:SRPT) rating on Tuesday, September 12. The company was upgraded on Monday, October 2 by Morgan Stanley.

Investors now seemed to have turned increasingly nervous following the Washington Post report on Tuesday, suggesting that Senate Republicans may delay corporate tax cut by 1-year. As per Wednesday, March 9, the company rating was maintained by JMP Securities. The rating was maintained by Roth Capital with "Buy" on Thursday, August 20.

Jason Karp decreased its stake in Sarepta Therapeutics Inc (Put) (SRPT) by 6.3% based on its latest 2017Q2 regulatory filing with the SEC. Leerink Swann reiterated an "outperform" rating and issued a $66.00 target price on shares of Sarepta Therapeutics in a research note on Saturday, September 30th. Needham maintained it with "Buy" rating and $55 target in Friday, October 2 report. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and sixteen have given a buy rating to the company. Oclaro Inc had 38 analyst reports since August 18, 2015 according to SRatingsIntel. Jefferies maintained it with "Buy" rating and $1200 target in Friday, June 9 report. The rating was maintained by Oppenheimer on Thursday, August 3 with "Buy". Finally, Piper Jaffray Companies reissued an "overweight" rating and set a $55.00 price objective (up from $50.00) on shares of Sarepta Therapeutics in a report on Thursday, September 7th. The rating was maintained by Oppenheimer on Wednesday, April 6 with "Outperform". The firm has "Buy" rating given on Monday, September 11 by Piper Jaffray. The firm earned "Buy" rating on Thursday, October 6 by Jefferies. Needham maintained Oclaro Inc (NASDAQ:OCLR) rating on Wednesday, February 3. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Like this



10 November 2017
German nurse may have killed more than 100 patients, prosecutors say
Now investigators believe he may have killed another 62 patients at one clinic and 38 patients at another, between 1999 and 2005. Additional convictions could affect Hoegel's possibility of parole, but there are no consecutive sentences in Germany.

10 November 2017
NBC To Air Steelers/Titans With SkyCam As Primary Viewing Angle
Titans writer Jim Wyatt sent out multiple tweets on Thursday breaking down how the new look will impact the viewing experience. The Steelers-Titans game , which is scheduled to kick off at 7:30 p.m., features two AFC teams now in first place.

10 November 2017
Saudi Arabia advises its citizens against traveling to Lebanon
The coalition government he led brought together nearly all of the main political parties in Lebanon, including Hezbollah. Expanding on the reasons for Hariri's resignation, Jubeir said the decision was precipitated by Hezbollah's actions.

10 November 2017
Chick-fil-A builds "Rivalry Restaurant" near state line for Auburn/UGA game
Former UGA quarterback David Greene and Auburn linebacker Takeo Spikes will also be in attendance. Auburn University football game (the first game was played at Piedmont Park in 1892).

10 November 2017
Apple moves worldwide cash to Jersey for tax reasons
According to the New York Times , Apple has $236bn in Irish shell companies, followed by Pfizer at $178bn and Microsoft at $146bn. Mr Cook responded defiantly: "We pay all the taxes we owe, every single dollar". "It will need to be addressed", Brady said.

10 November 2017
Panthers' Olsen to test broadcasting skills for Fox
Carolina Panthers tight end Greg Olsen is getting another jump on his broadcasting career this week with his team on a bye. For this gig, Olsen will be in a three-man booth alongside play-by-play man Kevin Burkhardt and analyst Charles Davis.

10 November 2017
Damascus suburb of 400000 faces "catastrophe" without aid: United Nations official
In Eastern Ghouta, Egeland said there are signs of "acutely malnourished" children and people are dying because it is impossible to have a medical evacuation.

10 November 2017
Hyeon Chung claims semi-final place at NextGen ATP Finals in Milan
The Croatian beat Daniil Medvedev 4-3 (5), 2-4, 4-1, 4-2 in an hour and 34 minutes. "The first two sets were extremely tough". Shapovalov will play his final group match on Thursday against Andrey Rublev of Russian Federation , who is also 1-1 so far.

10 November 2017
United Technologies Corporation (NYSE:UTX) Position Reduced by Everett Harris & Co. CA
Walter And Keenan Financial Consulting Company Mi Adv holds 0.91% in United Technologies Corporation (NYSE:UTX) or 14,850 shares. Moreover, Saratoga Research Invest Mgmt has 6.1% invested in United Technologies Corporation (NYSE:UTX) for 628,457 shares.

10 November 2017
Prince Harry Jokes with Fan About Meghan Markle's Whereabouts
Prince Harry has honoured the nation's war dead and joked with one veteran about bringing Meghan Markle to the event next year. Got a story tip? But it's understandable why he'd want to keep her a bit more out of the limelight.